USPTO serial 79296324
ORPHALAN INNOVATION FOR ORPHAN DISEASES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 28, 2021
- Examiner
- BETTS, MARCYA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ORPHALAN INNOVATION FOR ORPHAN DISEASES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | diagnostic agents for pharmaceutical use; capsules sold empty for pharmaceutical use; pharmaceutical compounds for the treatment of orphan diseases; pharmaceutical products for the treatment of orphan diseases; chemical preparations for pharmaceutical use, namely, for the treatment of orphan diseases; chemical preparations for medical use, for the treatment of orphan diseases; medicines for the development of treatment for orphan diseases | ACTIVE | — |
| 010 | Medical apparatus and instruments for diagnosing and treating orphan diseases; surgical apparatus and instruments; diagnostic apparatus for medical use for diagnosing orphan diseases; immunochemical testing apparatus for medical use; medical testing instruments for diagnosing and treating orphan diseases; substance analysis apparatus, namely, medical devices and medical instruments for the analysis of body fluids; instruments for extraction of liquids from the human body, namely, medical devices for obtaining body fluid samples; blood testing apparatus; radiology apparatus for medical use; blood testing instruments, namely, needles for medical use and veterinary use; resuscitation apparatus; gloves for medical use; gloves for veterinary use; syringes for medical use; fluid injectors for medical use; X-rays for medical use; inhalers for medical use; radiology screens for medical use; containers for applying medicines being medical tubing for administering drugs; special containers for medical waste; probes for medical use; thermometers for medical use; medical cases, namely, cases fitted for medical instruments; stethoscopes; heart pacemakers; electromagnetic diagnostic imaging apparatus for medical use; needles for medical use | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; development of pharmaceutical products; providing information on clinical studies for pharmaceutical products via an interactive website; evaluation of pharmaceutical products; scientific research in the field of pharmacy; research regarding pharmaceutical products; pharmaceutical research and development; research relating to pharmaceutical products; research and development for the pharmaceutical industry; conducting clinical trials for other in the field of pharmaceutical products; pharmaceutical drug development services; laboratory research services relating to pharmaceutical products; pharmaceutical research services; medical and pharmacological research services; pharmaceutical research and development services; Scientific research for medical purposes; scientific laboratory services; research and development in the field of biotechnology; design and development of medical diagnostic apparatus | ACTIVE | — |
| 044 | Advice relating to pharmacy, namely, advice relating to the use of pharmaceuticals for the treatment of orphan diseases; advisory services relating to health; pharmaceutical advice; advice relating to medicines; information to patients on administering medicines; medical information; drug use testing service for medical use; pharmaceutical services, namely, pharmaceutical compounding services and information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; medical testing and analysis services for diagnostic or treatment of orphan disease; health advisory services relating to the use and operation of medical apparatus and instruments for treatment of orphan disease; medical diagnosis of orphan diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ORPHALAN
- Other trademarks owned by ORPHALAN
- Other trademarks owned by ORPHALAN
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ORPHALAN INNOVATION FOR ORPHAN DISEASES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 9, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 28, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 4, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 22, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 22, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 22, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 8, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 8, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 28, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |